physiolog basi endocrin therapi prostat cancer advanc understand hypothalamic-pituitari gonad regul develop pharmaceut agent castrat state minim morbid select method androgen ablat patient stage adenocarcinoma prostat patient prefer cost therapeut outcom medic castrat orchiectomi equival addit androgen receptor patient regimen knowledg impact mortal rate modest cost signific further manipul androgen product action patient resist cancer unlik diseas progress mortal rate effort develop effect chemotherapi diseas 